Chugai Pharma UK Limited

Mulliner House, Flanders Road, Turnham Green, London, W4 1NN
Telephone: +44 (0)208 987 5600
Fax: +44 (0)208 987 5660

Patient Information Leaflet last updated on the eMC: 03/11/2011
PIL Antepsin 1g/5ml Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2011 and displayed until Current
Reasons for adding or updating:
  • Unknown
Updated on 12/11/2010 and displayed until 03/11/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 14/09/2009 and displayed until 12/11/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 01/12/2006 and displayed until 14/09/2009
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to Further Information section
  • Change to date of revision
Updated on 26/10/2006 and displayed until 01/12/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 19/04/2006 and displayed until 26/10/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   sucralfate